Champ L. Baker, Jr., MD, performed the procedure at Jack Hughston Memorial Hospital in Phoenix City, Ala. The company intends to make a full market release of its FDA 510(k)-approved ExoShape device in June 2011.
The device features a non-rotational deployment technique designed to preserve the soft tissue graft bundle orientation and tension during single-tunnel double-bundle procedures. The use of MedShape’s proprietary PEEK Altera polymer allows the sheath to be pre-compressed for easy insertion and then expand for graft-to-tunnel compression.
Read the MedShape Solutions news release on the ExoShape.
Read other coverage on orthopedic and spine implant news:
– OrthoSensor Receives $21M in Series B Financing
– ConforMIS Receives FDA Approval for iTotal Patient-Specific Total Knee Replacement
– X-Spine Receoves FDA 510(k) Clearance on AXLE Interspinous Fusion System
